About Us
NEUROSTECH is the only biotechnology company in the world that has designed, patented, tested and is developing human prototypes of pumpless devices and smart catheters for the intrathecal delivery of drugs. Our proprietary technology enables the development of novel, IP protected, medical devices to treat neurological diseases by implement the safest solution to administer therapies.
Our technology takes advantage of modern CSF dynamics theory and allows development of medical devices for drug combination modalities not possible by other strategies. NEUROSTECH intrathecal precision dosing and biodistribution platform incorporates deep knowledge of CSF dynamics and bioengineering.
The company integrates innovation in neuroscience, precision dosing platforms, and manufacturing capabilities to deliver transformative therapies to patients. Fully implantable devices enable the continuous clearance of toxic CNS proteins, a strategy aimed to treat neurodegenerative proteinopathies like Alzheimer’s disease, Parkinson, ALS, etc.
NEUROSTECH is a biotechnology company founded as a spin-off of the Fundación Neurociencias in Oviedo (Spain), and led by its cofounder Manuel Menéndez, MD, Ph.D., and supported by collaborations with leading neuroscientists in Europe and the USA, as well as by experienced managers, scientists and Business Development professionals.
